VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 60 filers reported holding VOR BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $220,306 | -31.4% | 103,918 | 0.0% | 0.00% | – |
Q2 2023 | $321,107 | +235.5% | 103,918 | +484.1% | 0.00% | – |
Q1 2023 | $95,721 | +32.4% | 17,792 | +63.6% | 0.00% | – |
Q4 2022 | $72,319 | +64.4% | 10,875 | 0.0% | 0.00% | – |
Q3 2022 | $44,000 | -78.7% | 10,875 | -73.8% | 0.00% | – |
Q2 2022 | $207,000 | -63.4% | 41,476 | -55.7% | 0.00% | – |
Q1 2022 | $566,000 | -47.3% | 93,586 | +1.4% | 0.00% | – |
Q4 2021 | $1,073,000 | -23.5% | 92,335 | +3.2% | 0.00% | – |
Q3 2021 | $1,403,000 | +8.9% | 89,456 | +29.6% | 0.00% | – |
Q2 2021 | $1,288,000 | -59.2% | 69,030 | -5.7% | 0.00% | -100.0% |
Q1 2021 | $3,157,000 | – | 73,241 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 6,361,723 | $73,923,000 | 13.88% |
RA Capital Management | 11,120,973 | $129,226,000 | 2.28% |
Paradigm Biocapital Advisors LP | 629,342 | $7,313,000 | 2.09% |
OUP Management Co., LLC | 374,714 | $4,354,000 | 1.96% |
JOHNSON & JOHNSON | 1,074,658 | $12,488,000 | 1.42% |
Sarissa Capital Management LP | 707,010 | $8,215,000 | 0.71% |
Woodline Partners LP | 1,111,123 | $12,911,000 | 0.18% |
Artal Group S.A. | 550,000 | $6,391,000 | 0.17% |
Orbimed Advisors | 833,333 | $9,683,000 | 0.12% |
Laurion Capital Management LP | 857,308 | $9,962,000 | 0.10% |